Douglas Bucklin Ph.D. Moderating Panel at Life Sciences Masters 2022
10.19.2022
On October 26, 2022, Senior Attorney Douglas Bucklin, Ph.D. will be moderating a panel discussing the impact of GSK v. Teva on "skinny labeling," subsequent cases, and industry considerations.
The panel discussion Strategic Considerations for Generics and Brands in Light of GSK v. Teva is part of IP Watchdog’s Inaugural Life Sciences Masters program. The panelists include Emer Simico of Neal Gerber Eisenberg, Melissa Brand with Radius Health Inc. and Luke Shannon of Polsinelli.